Tao Wang

机构：Hebei Medical University, Foshan University, Wuhan University, Third Hospital of Hebei Medical University, The First Hospital of Kunming, Ankang City Central Hospital, Renmin Hospital of Wuhan University, Hainan Medical University · ORCID：0000-0001-5982-6825

发表论文 47 篇 · 总被引 1784 次 · h-index 20

代表论文

• Abnormal immunity of non-survivors with COVID-19: predictors for mortality (2020 · Infectious Diseases of Poverty · 被引 113)
• Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis (2020 · European Journal of Clinical Microbiology & Infectious Diseases · 被引 83)
• A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial (2020 · Virologica Sinica · 被引 82)
• Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases (2020 · Virologica Sinica · 被引 68)
• Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial (2020 · Clinical Infectious Diseases · 被引 58)
• Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction (2018 · Medical Science Monitor · 被引 51)